Vor(VOR) - 2022 Q3 - Quarterly Report
Vor(VOR)2022-11-10 21:06(Mark One) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 OR For the transition period from __________________ to __________________ Commission File Number: 001-39979 VOR BIOPHARMA INC. (Exact Name of Registrant as Specified in its Charter) (State or other jurisdiction of incorporation or organization) 100 Cambridgepark Drive, Suite 101 Cambridge, Massachusetts 02140 (Address of princip ...